Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude First To Market Leadless Pacemaker With Nanostim Buy

This article was originally published in The Gray Sheet

Executive Summary

St. Jude paid $123.5 million and agreed to up to $65 million in additional milestone payments to acquire Nanostim and its first-in-class leadless pacemaker, which has just earned a CE mark and is expected to launch in select European markets soon.

Advertisement

Related Content

Medtronic Receives CE Mark For World’s Smallest Pacemaker
Medtronic Enters Leadless Pacemaker Competition With Micra CE Mark
Device/Diagnostics Quarterly Deal Statistics, Q4 2013
Medtronic Goes Small With Leadless Pacer, Cardiac Monitor
Research Briefs: St. Jude’s Leadless Pacemaker, Gore’s Thoracic Branch Endoprosthesis
Research Briefs: Esophageal Stent Removal; Pill-Sized Pacer; Spinal-Stim Pain Relief; Prestige
CardioMEMS Has Better Luck With FDA Advisory Panel Second Time Around
SJM’s Endosense Deal Highlights Growing Importance Of Contact Force Technology In AF Ablation
St. Jude Medical: Cardiac Rhythm Management Business Has “Turned The Corner”
St. Jude Outlines Strategy To Revive Pacemaker Business

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel